We are live on ! Find out more
INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

86 hedge funds and large institutions have $197M invested in Insys Therapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 15

33% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 21

31% more capital invested

Capital invested by funds: $151M → $197M (+$46.4M)

21% more funds holding

Funds holding: 71 → 86 (+15)

18% more call options, than puts

Call options by funds: $925K | Put options by funds: $782K

Holders
86
Holders Change
+15
Holders Change %
+21.13%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
30
Increased
28
Reduced
21
Closed
15
Calls
$925K
Puts
$782K
Net Calls
+$143K
Net Calls Change
+$143K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$12.1M
2
BFA
BlackRock Fund Advisors
California
+$10M
3
TCM
Tamarack Capital Management
California
+$9.78M
4
JHIU
Janus Henderson Investors US
Colorado
+$9.41M
5
Bank of America
Bank of America
North Carolina
+$5.1M

Top Sellers

Rank Fund Capital Flow
1
EA
Emerald Advisers
Pennsylvania
-$9.52M
2
JP Morgan Chase
JP Morgan Chase
New York
-$5.65M
3
Renaissance Technologies
Renaissance Technologies
New York
-$5.52M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$4.35M
5
BA
BlackRock Advisors
Delaware
-$3.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFU
76
Stonehage Fleming (UK)
United Kingdom
$32K +$34.2K +2,463 New
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$19K -$374K -26,952 -95%
Teacher Retirement System of Texas
78
Teacher Retirement System of Texas
Texas
$8K +$8.32K +600 New
GC
79
Globeflex Capital
California
$6K – – –
BlackRock
80
BlackRock
New York
$5K – – –
HF
81
Hoxton Financial
West Virginia
$5K +$1.66K +120 +51%
RIA
82
Regal Investment Advisors
Michigan
$5K +$4.99K +360 New
TRCT
83
Tower Research Capital (TRC)
New York
$4K -$27.5K -1,983 -87%
Creative Planning
84
Creative Planning
Kansas
$3K – – –
Ameriprise
85
Ameriprise
Minnesota
$1K -$1.5M -107,865 -100%
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$170 +$156K +11,244 +584%
JP Morgan Chase
87
JP Morgan Chase
New York
– -$5.65M -484,644 Closed
Renaissance Technologies
88
Renaissance Technologies
New York
– -$5.52M -473,100 Closed
EI
89
EAM Investors
California
– -$2.62M -224,673 Closed
RFC
90
Russell Frank Company
Washington
– -$1.85M -167,484 Closed
RA
91
Royce & Associates
New York
– -$1.61M -138,240 Closed
GC
92
Guggenheim Capital
Illinois
– -$1.5M -128,172 Closed
ARTA
93
A.R.T. Advisors
New York
– -$1.47M -126,027 Closed
Wellington Management Group
94
Wellington Management Group
Massachusetts
– -$952K -81,600 Closed
EMG
95
Ellington Management Group
Connecticut
– -$637K -54,600 Closed
Two Sigma Investments
96
Two Sigma Investments
New York
– -$391K -33,552 Closed
OAM
97
Oberweis Asset Management
Illinois
– -$388K -33,300 Closed
SCA
98
SAC Capital Advisors
Connecticut
– -$280K -23,991 Closed
BJ
99
BlackRock Japan
Japan
– -$144K -12,345 Closed
California Public Employees Retirement System
100
California Public Employees Retirement System
California
– -$7K -600 Closed
1 2 3
4
5

INSY Hedge Fund Activity: Q4 2013 in Review

86 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q4 2013, worth a combined $197M — up 31% from $151M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new INSY positions and 15 closed out — a net gain of 15 holders — while 28 added to existing stakes and 21 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $12.1M. The largest seller was Emerald Advisers, cutting an estimated $9.52M.

  • 86 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q4 2013, up from 71 in Q3 2013.
  • Funds reported $197M of Insys Therapeutics, Inc. stock for Q4 2013, up 31% quarter-over-quarter.
  • 30 funds opened new Insys Therapeutics, Inc. positions in Q4 2013 and 15 closed out, a net change of +15 holders.
  • The largest Insys Therapeutics, Inc. buyer in Q4 2013 was Consonance Capital Management, an estimated $12.1M added.
  • The largest Insys Therapeutics, Inc. seller in Q4 2013 was Emerald Advisers, an estimated $9.52M sold.

Based on aggregated 13F filings for Q4 2013.